ConductScience.org, home

Trial · NCT04861064

Weekly Sirolimus Therapy

NCT04861064, Phase 2, Recruiting, Medical University of South Carolina

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Weekly Sirolimus Therapy. Trials, record NCT04861064. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04861064

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Weekly Sirolimus Therapy
NCT number
NCT04861064
Status
Recruiting
Phases
Phase 2
Enrollment
24 participants, estimated
Lead sponsor
Medical University of South Carolina
Conditions
Venous Malformation, Lymphatic Malformation
Interventions
Sirolimus
First posted
2021-04-27
Last updated
2026-03-05

Source ClinicalTrials.gov

Registered outcomes10

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in size of lesionBaseline and 6 monthsWill be measuring the size of the lesions (mm) at each patient visit
PrimaryChange in size of lesion through photographBaseline and 6 monthsWill be evaluating clinical photographs of lesions at each patient visit
SecondaryNumber of side effects experiencedMonth OnePatient will complete side effect questionnaires at each visit
SecondaryNumber of side effects experiencedMonth TwoPatient will complete side effect questionnaires at each visit
SecondaryNumber of side effects experiencedMonth ThreePatient will complete side effect questionnaires at each visit
SecondaryNumber of side effects experiencedMonth FourPatient will complete side effect questionnaires at each visit
SecondaryNumber of side effects experiencedMonth FivePatient will complete side effect questionnaires at each visit
SecondaryNumber of side effects experiencedMonth SixPatient will complete side effect questionnaires at each visit
SecondaryChange in quality of life as assessed by questionnaireBaseline and 6 monthsPatient will complete quality of life questionnaire at each visit
SecondaryNumber of participants with laboratory abnormalitiesFrom baseline visit to 2 month visitStandard of care laboratory results (CBC, CMP, triglycerides) will be monitored

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04861064

GET https://conductscience.org/api/trials/v1/NCT04861064/registered